Andere Sprachen Avacta Group Plc

Aktien

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:21 01.05.2024			% 5 Tage	% 1. Jan.
46,75 ^GBX	+2,19 %		+5,06 %	-59,87 %

30.04.	Avacta Group CEO tritt zurück; Nachfolger ernannt	MT
30.04.	Transcript : Avacta Group Plc, 2023 Earnings Call, Apr 30, 2024

Avacta Group plc - Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	01.05.
Avacta picks Christina Coughlin to replace long-serving CEO	01.05.
EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down	30.04.
Avacta Group CEO Steps Down; Successor Appointed	30.04.
Avacta : Results for the Year Ended 31 December 2023	30.04.
Avacta : Preliminary Results for the Year Ended 31 December 2023	30.04.
Avacta : Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	30.04.
Avacta Group Plc Reports Earnings Results for the Full Year Ended December 31, 2023	30.04.
Avacta Group plc Announces Chief Executive Officer Changes	30.04.
Avacta : R&D Spotlight series – Episode 2	25.04.
Avacta Group plc - Block Listing Application to AIM	24.04.
Avacta Group plc - Notice of Results	24.04.
First Tin updates Tellerhauser estimates	22.04.
Avacta Therapeutics Reports Data from the Ongoing Phase 1 Clinical Trial of AVA6000 at the AACR Annual Meeting Demonstrating Clinical Proof-of-Concept Showing Multiple Patient Responses	10.04.
Avacta Group plc Reports Data from the Ongoing Phase 1 Clinical Trial of AVA6000 At the AACR Annual Meeting	09.04.
Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update	05.04.
Avacta : Glossary	05.04.
Avacta : Research and Development Spotlight Series – Episode 1	27.03.
Avacta doses third patient in drug conjugate trial for tumour tissue	21.03.
Avacta shareholders give AGM go-ahead to issue new shares	18.03.

Keine Ergebnisse zu dieser Suche